Mohammed A. AlOmar: What Characterizes Young Stroke in the UAE?
Mohammed A. AlOmar, Scholar at Sheikh Saud bin Saqr Al Qasimi Foundation for Policy Research, Medical Intern at EHSUAE, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers in Neurology, adding:
“Proud to see our work published and available for others to read and build on.
In this paper, we looked at what characterizes young stroke in the UAE.
We reviewed every young stroke case at our hospital over six years and analyzed the data to better understand a population that remains relatively understudied.
What started as a study of stroke etiology ended up highlighting a broader primary care gap. Younger stroke patients carried a high cardiometabolic burden, but we also found evidence of underdiagnosis, particularly when compared with reported data from other parts of the world.
A special thank you to my co-authors Dr Basma Alomar, Dr Lamees Alsalehi, Dr Abdulrahman Said Adan, Dr Aya Alsayyad, Dr Ammar Al-Omar for making this paper as comprehensive and enjoyable as it was with many opinions, minds and expertise involved in the making of this paper.”
Title: The silent risk: cardiometabolic burden and etiology of young stroke in a South Asian migrant cohort, United Arab Emirates
Authors: Mohammed AlOmar, Basma AlOmar, Lamees Alsalehi, Abdulrahman Said Adan, Aya Alsayyad, Ammar Fadhil AlOmar
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 24, 2026, 18:27Kemal Karaagac: Early DOAC Initiation After Acute Ischaemic Stroke in Atrial Fibrillation
-
Sep 24, 2026, 18:12Alan Nurden: How Genotype and Phenotype Can Vary in von Willebrand Disease
-
Sep 24, 2026, 16:02Leonardo Roever: Understanding Peripheral Artery Disease in the Modern Era
-
Sep 24, 2026, 15:49Sthanu Subramanian: When HbA1c Does Not Reflect True Glycemia
-
Sep 24, 2026, 15:09Caroline Voltz-Girolt: Accelerating the Development of Innovative Therapies for Rare Blood Disorders
-
Sep 24, 2026, 15:00Gambo Ramatu: Anemia as a Preventable Pregnancy Challenge
-
Sep 24, 2026, 14:56Holly John: Sickle Cell Disease Beyond Pain and Clinical Outcomes
-
Sep 24, 2026, 14:45Bruce Holland: Ex Vivo Assessment of ActiGraft Clot Formation Under Anticoagulation
-
Sep 24, 2026, 14:33Mohamed El Belghiti Alaoui: Thrombin as a Therapeutic Target in Coagulation